ESC 365 - Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy

ESC Premium Access

Clinical outcomes at two years of the Absorb BRS vs. the Xience metallic DES in patients presenting with ACS vs. stable coronary disease - AIDA trial substudy

Session: Innovative strategies in percutaneous coronary intervention

Topic: Revascularisation

Speaker: Doctor R. Tijssen (Nieuwegein, NL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Doctor Ruben Tijssen

St Antonius Hospital, Nieuwegein (Netherlands (The))

0 follower

5 more presentations in this session

Clinical impact of residual SYNTAX score after physiology guided state-of-art PCI in 3VD: insight from the SYNTAX II trial

Speaker: Doctor N. Kogame (Amsterdam, NL)

Mechanism and impact of lesion morphology on the late lumen loss of drug-eluting resorbable magnesium scaffolds: a serial optical coherence tomography study

Speaker: Doctor Y. Ueki (Matsumoto, JP)

Effects of scoring or cutting balloon use on severely calcified lesions treated by percutaneous coronary intervention

Speaker: Doctor A. Ikuta (Kurashiki, JP)

Impact of intimal tracking for recanalization of CTO lesions on long-term clinical outcomes

Speaker: Doctor S. Kano (Toyohashi, JP)

Incidence and outcomes of bailout stenting following use of drug coated balloon

Speaker: Doctor H. Salim (London, GB)

Access the full session

Innovative strategies in percutaneous coronary intervention

Speakers: Doctor R. Tijssen, Doctor N. Kogame, Doctor Y. Ueki, Doctor A. Ikuta, Doctor S. Kano...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources